Trials / Unknown
UnknownNCT04304313
A Pilot Study of Sildenafil in COVID-19
A Pilot Study of Sildenafi in the Treatment of COVID-19
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observe the efficacy and safety of G1(Sildenafil citrate tablets) in patients with COVID-19 under clinical actual diagnosis and treatment conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil citrate tablets | 0.1g/day for 14 days |
Timeline
- Start date
- 2020-02-09
- Primary completion
- 2020-03-01
- Completion
- 2020-11-09
- First posted
- 2020-03-11
- Last updated
- 2020-03-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04304313. Inclusion in this directory is not an endorsement.